Brind.

Norgine's ex-U.S. PEDMARQSI launched, with successful initial uptake reported during clinical trial STS-J01 in Japan.

3 reports, 1 independent Updated Aug 5

Gone quiet

Reports: 3
Developments: 1
Repetition: 67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Norgine's ex-U.S. PEDMARQSI launched, with successful initial uptake reported during clinical trial STS-J01 in Japan.

Who's involved

What this event is mainly about

Norgine CIO Japan

Keep exploring

The entities involved

Norgine
company in Amsterdam, Netherlands

Nothing else this week.
CIO
Charger manufacturer in Japan

Nothing else this week.
Japan
- Japan is deepening economic cooperation with Sri Lanka through knowledge exchange, guided by Japanese principles.Mon 11:09
- Sri Lanka joined the Sterling Assets Agreement and participated in the San Francisco Conference.Mon 11:09

Coverage

Newest first; wire copies grouped

Aug 14GlobeNewswireFennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business Update ~ Achieved Second Quarter 2025 Total Net Revenues of $9.7 Million ~ ~ Double Digit New Accounts in th
Aug 11GlobeNewswireFennec Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 14, 2025 RESEARCH TRIANGLE PARK, N.C., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TS

1 more outlet ran the same wire story

Aug 5manilatimes.net